IMMVF Immunovia AB (publ)

USD 0.15 0.00 0
Icon

Immunovia AB (publ) (IMMVF) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.15

0.00 (0.00)%

USD 7.23M

N/A

N/A

N/A

Icon

IMMVF

Immunovia AB (publ) (USD)
COMMON STOCK | OTC
USD 0.15
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 7.23M

N/A

USD 0.15

Immunovia AB (publ) (IMMVF) Stock Forecast

N/A

Based on the Immunovia AB (publ) stock forecast from 0 analysts, the average analyst target price for Immunovia AB (publ) is not available over the next 12 months. Immunovia AB (publ)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Immunovia AB (publ) is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Immunovia AB (publ)’s stock price was USD 0.15. Immunovia AB (publ)’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -95.25% over the last year.

No recent analyst target price found for Immunovia AB (publ)
No recent average analyst rating found for Immunovia AB (publ)

Company Overview Immunovia AB (publ)

Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headqua...Read More

https://www.immunovia.com

Medicon Village, Lund, Sweden, 223 63

11

December

USD

USA

Adjusted Closing Price for Immunovia AB (publ) (IMMVF)

Loading...

Unadjusted Closing Price for Immunovia AB (publ) (IMMVF)

Loading...

Share Trading Volume for Immunovia AB (publ) Shares

Loading...

Compare Performance of Immunovia AB (publ) Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for IMMVF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Immunovia AB (publ) (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LZAGF
Lonza Group Ltd -11.72 (-2.10%) USD42.40B 60.22 29.26

ETFs Containing IMMVF

Symbol Name IMMVF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Immunovia AB (publ) (IMMVF) Stock

Stock Target Advisor's fundamental analysis for Immunovia AB (publ)'s stock is Slightly Bearish.

Unfortunately we do not have enough data on IMMVF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on IMMVF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on IMMVF's stock to indicate if its overvalued.

The last closing price of IMMVF's stock was USD 0.15.

The most recent market capitalization for IMMVF is USD 7.23M.

Unfortunately we do not have enough analyst data on IMMVF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Immunovia AB (publ)'s stock.

As per our most recent records Immunovia AB (publ) has 11 Employees.

Immunovia AB (publ)'s registered address is Medicon Village, Lund, Sweden, 223 63. You can get more information about it from Immunovia AB (publ)'s website at https://www.immunovia.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...